Major Depressive Disorder (MDD)

You May Quality for the MDD Study, If:

• At least 18 years of age” instead of “Ages 18-65
• If you have been struggling with Major Depressive Disorder characterized by persistent feelings of sadness or loss of interest that can lead to a range of behavioral and physical symptoms
• If you are currently in a depressive episode lasting more than 4 weeks

The MCC study is evaluating an investigational medication, in combination with an approved antidepressant, for the treatment of TRD. The investigational medication in this study is approved for use in the United States. It is believed to work via pathways that are markedly different from most currently approved drugs. Doctors believe the combination of the investigational medication and an antidepressant could revolutionize the treatment of depression.

All study-related visits, tests, and drugs may be provided at no cost. In addition, reimbursement for studyrelated travel may be provided.
The study will include approximately 8 visits over approximately 6 weeks.

** Announcement **
On January 23rd, our current electronic health system will transition to a new and advanced system to better serve you: Athena. Prior to the transition date, you will be sent a registration link to create a new patient account in Athena. If you have any immediate questions or concerns, please do not hesitate to contact your therapist, or call our office to speak to a staff member.